3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
Breast
1
Conditions
Squamous Cell Carcinoma of Head and Neck
17
Head and Neck Neoplasms
10
Melanoma
9
Carcinoma, Non-Small-Cell Lung
8
Neoplasms
6
Neoplasm Metastasis
6
Urinary Bladder Neoplasms
5
Triple Negative Breast Neoplasms
5
Breast Neoplasms
5
Uterine Cervical Neoplasms
4
Stomach Neoplasms
4
Ovarian Neoplasms
4
Mouth Neoplasms
4
Colorectal Neoplasms
4
Carcinoma, Merkel Cell
4
Carcinoma, Hepatocellular
4
Pancreatic Neoplasms
3
Oropharyngeal Neoplasms
3
Laryngeal Neoplasms
3
Colonic Neoplasms
3
Thyroid Neoplasms
2
Thyroid Carcinoma, Anaplastic
2
Sarcoma
2
Recurrence
2
Prostatic Neoplasms
2
Kidney Neoplasms
2
Gastrointestinal Neoplasms
2
Carcinoma, Squamous Cell
2
Carcinoma, Renal Cell
2
Carcinoma
2
Interventions
cemiplimab
1
advexin
1
Erlotinib Hydrochloride
1
Aminolevulinic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma in Situ
×
cemiplimab
×
Head & Neck
×
Clear all
NCT06022029
2025-12-24
ON-5001
OncoNano Medicine, Inc.
Phase 1
Recruiting
168 enrolled